Cefodizime: pharmacological characteristics and potential for clinical use in lower respiratory tract infections | CMAC

Cefodizime: pharmacological characteristics and potential for clinical use in lower respiratory tract infections

Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):277-282

Section
Type
Review

Abstract

Cefodizime is a third–generation cephalosporin for parenteral use that has become available for the first time in the Russia. This paper reviews the use of this antibiotic in clinical practice based on the current data on antimicrobial resistance in pathogens causing lower respiratory tract infections and the results of completed clinical studies of its efficacy and safety.

Views
0 Abstract
0 PDF
0 Crossref citations
Shared